Zach McLellan, Kevin Shannon, Jack Allen and Ines Mihel discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast.
Topics covered in this episode include:
- CAR T catch-up - Gilead purchase of Kite, Kymriah approval (GILD, KITE, NVS) - 0:32
- Cellectis UCART123 clinical hold (CLLS) - 10:00- Eli Lilly update on baricitinib development (LLY INCY) - 15:50
- Fitusiran clinical hold(ALNY) - 24:04
To learn more about Datamonitor Healthcare and our offerings, visit: https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/datamonitor-healthcare
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: